SMTL ID : 5lma.1

HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.43 Å

Oligo State

monomer

Ligands

1 x 6ZG: ~{N}'-[7-(4-methylphenyl)pyrido[3,4-b]pyrazin-5-yl]butane-1,4-diamine(Non-covalent)

6ZG.1: 16 residues within 4Å: Chain A: L.19, G.20, V.27, A.42, E.91, M.92, A.93, E.94, L.95, G.96, P.97, R.140, N.141, L.143, D.154 Ligands: GOL.2 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.19 Hydrogen bonds: A:A.93, A:R.140

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 7 residues within 4Å: Chain A: V.27, K.44, E.62, M.90, S.153, D.154 Ligands: 6ZG.1 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:E.62, A:D.154 Water bridges: A:E.62, A:F.155 GOL.3: 4 residues within 4Å: Chain A: V.5, A.63, N.64, Q.67 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:V.5, A:A.63 Water bridges: A:Q.67, A:I.80

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.4: 1 residues within 4Å: Chain A: N.48 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.48 Water bridges: A:N.48

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Garton, N.S. et al., Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors. Bioorg.Med.Chem.Lett. (2016)

Release Date

2016-09-14

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence